Key result
MPI score 1 linked to ~43% lower 3-year mortality vs scores 2-3 in older TAVI patients.
Why the study?
Selecting patients with a high chance of enduring benefit from TAVI is relevant due to changing indications and increasing TAVI procedures, but prognostic tools are needed.
Does the multidimensional prognostic index (MPI) predict overall survival in older patients undergoing TAVI?
Observational (n=376)
No
Does the multidimensional prognostic index (MPI) predict overall survival in older patients undergoing TAVI?
The multidimensional prognostic index (MPI) based on comprehensive geriatric assessment is a useful tool to assess frailty and predict long-term survival benefit in older patients undergoing TAVI.
Answers are grounded in this paper and cite their sources.
May refine risk stratification in older TAVI patients; hypothesis-generating and requires prospective validation before clinical adoption.
Selecting patients with a high chance of endured benefit from transcatheter aortic valve implantation (TAVI) is becoming relevant with changing indications and increasing number of TAVI being performed. The aim of our study was to investigate the association of the multidimensional prognostic index (MPI) based on a comprehensive geriatric assessment (CGA) on survival. The TAVI Care & Cure program is a prospective, observational registry of patients referred for TAVI at the Erasmus MC University Medical Center. Consecutive patients who underwent a complete CGA and TAVI were included. CGA components were used to calculate the MPI score. The impact of the MPI score on survival was evaluated using Cox regression. Furthermore, 376 patients were included, 143 (38.0%) patients belonged to the MPI-1 group and 233 (61.9%) patients to the MPI-2–3 group. After 3 years, 14.9% of the patients in the MPI-1 group and 30.5% of the patients in the MPI-2–3 group died (p = 0.001). Patients in MPI-1 had increased chances of overall survival in comparison with patients in MPI group 2–3 Hazard Ratio (HR) 0.57, (95% Confidence Interval (CI) 0.33–0.98)). In this study we found that the MPI tool could be useful to assess frailty and to predict which patient will have a higher chance of enduring benefit from a TAVI procedure.
No takes yet. Share an insight, caveat, or question.
Goudzwaard et al. (2021) conducted an observational in Patients referred for transcatheter aortic valve implantation (TAVI) (n=376). Multidimensional prognostic index (MPI) score 1 vs. MPI score 2-3 was evaluated on Mortality (HR 0.57, 95% CI 0.33-0.98, p=0.001). A multidimensional prognostic index score of 1 was associated with lower 3-year mortality compared to a score of 2-3 in older patients undergoing TAVI.
Synapse has enriched 10 related papers. Consider them for comparative context: